DuPont de Nemours, Inc. logo

DuPont de Nemours, Inc. (DD)

Market Closed
20 Jul, 20:00
NYSE NYSE
$
135. 75
+0.46
+0.34%
$
18.12B Market Cap
37.17 P/E Ratio
3.92% Div Yield
1.04M Volume
4.3 Eps
$ 135.29
Previous Close
Add Transaction
Day Range
134.91 138.47
Year Range
86.59 157.98
Want to track DD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DuPont Spinoff Qnity Starts Trading Today. What to Know.

DuPont Spinoff Qnity Starts Trading Today. What to Know.

Qnity Electronics supplies chemicals and materials to makes of semiconductors.

Barrons | 8 months ago
Why DuPont de Nemours (DD) Could Beat Earnings Estimates Again

Why DuPont de Nemours (DD) Could Beat Earnings Estimates Again

DuPont de Nemours (DD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 9 months ago
Why DuPont de Nemours (DD) is a Top Momentum Stock for the Long-Term

Why DuPont de Nemours (DD) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 10 months ago
DuPont de Nemours, Inc. (DD) Q2 2025 Earnings Call Transcript

DuPont de Nemours, Inc. (DD) Q2 2025 Earnings Call Transcript

DuPont de Nemours, Inc. (NYSE:DD ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants Ann Giancristoforo - VP for Investor Relations Antonella B. Franzen - Senior VP & CFO Edward D.

Seekingalpha | 11 months ago
Compared to Estimates, DuPont de Nemours (DD) Q2 Earnings: A Look at Key Metrics

Compared to Estimates, DuPont de Nemours (DD) Q2 Earnings: A Look at Key Metrics

The headline numbers for DuPont de Nemours (DD) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 11 months ago
DuPont Tops Estimates, Raises Outlook on Sales Increase, Lower Tariff Impact

DuPont Tops Estimates, Raises Outlook on Sales Increase, Lower Tariff Impact

DuPont (DD) shares rose Tuesday when the chemicals and materials manufacturer posted better-than-expected results and boosted its guidance on higher sales and volumes, plus a tax benefit. It also lowered its anticipated tariff hit.

Investopedia | 11 months ago
DuPont's Earnings & Sales Top Estimates in Q2 on Higher Volumes

DuPont's Earnings & Sales Top Estimates in Q2 on Higher Volumes

DD's Q2 earnings and sales top estimates, fueled by volume growth in ElectronicsCo and IndustrialsCo segments.

Zacks | 11 months ago
DuPont de Nemours (DD) Surpasses Q2 Earnings and Revenue Estimates

DuPont de Nemours (DD) Surpasses Q2 Earnings and Revenue Estimates

DuPont de Nemours (DD) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.97 per share a year ago.

Zacks | 11 months ago
DuPont de Nemours (DD) Earnings Expected to Grow: Should You Buy?

DuPont de Nemours (DD) Earnings Expected to Grow: Should You Buy?

DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 11 months ago
DuPont Launches FilmTec Hypershell for Energy-Efficient Dairy Processing

DuPont Launches FilmTec Hypershell for Energy-Efficient Dairy Processing

DuPont's FilmTec Hypershell XP RO-8038 boosts dairy processing with up to 50% more productivity or 50% less energy use.

Zacks | 1 year ago
DD Adds Sterile Packaging Capacity at Costa Rica Manufacturing Plant

DD Adds Sterile Packaging Capacity at Costa Rica Manufacturing Plant

DuPont's Costa Rica expansion introduces sterile healthcare packaging, a first for the region's medical device industry.

Zacks | 1 year ago
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now

Here's Why You Should Hold DuPont Stock in Your Portfolio for Now

Innovation, cost savings and healthcare acquisitions support DD as it navigates weak demand and hefty separation costs in 2025.

Zacks | 1 year ago
Loading...
Load More